US WorldMeds
Registered Principal Details
Business Or Interest:
US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs
Lobbying Interests:
Matters related to health care Medicaid and pharmacy.
CEO Name:
Brian Hicks
US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs
Lobbying Interests:
Matters related to health care Medicaid and pharmacy.
CEO Name:
Brian Hicks
Contact
BH
Brian Hicks
21 East State Street, Suite 2200
Columbus, OH 43215
(614) 221-2800
(614) 221-8976
stacy.schad@hickspartners.com
21 East State Street, Suite 2200
Columbus, OH 43215
(614) 221-2800
(614) 221-8976
stacy.schad@hickspartners.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Gregory Hubbard | Exclusive Duties No | Authorized On 9/19/2019 | Withdrawn On N/A |
| Katie White | Exclusive Duties No | Authorized On 9/19/2019 | Withdrawn On N/A |
| AJ Wilson | Exclusive Duties No | Authorized On 9/19/2019 | Withdrawn On N/A |
| Ramie Zelenkova | Exclusive Duties No | Authorized On 9/19/2019 | Withdrawn On N/A |
Lobbying Interests
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
COVID-19 related issues.
COVID-19 related issues.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/25/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/25/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Opioid antagonist administration in jails and
medication-assisted treatment availability in prisons and jails.
Development, drafting or introduction of a proposal relating to
Opioid antagonist administration in jails and medication-assisted treatment availability in prisons and jails.
Opioid antagonist administration in jails and medication-assisted treatment availability in prisons and jails.
Action Intended To Affect
Legislative matter
Notification Date
11/16/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
11/16/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 July - December $20,875.00 |
2020 January - June $30,000.00 |
2020 July - December $30,000.00 |
Total $80,875.00 |
| Total Hours Communicating | 2019 July - December 2.75 |
2020 January - June 6.25 |
2020 July - December 0.00 |
Total 9.00 |
| Total Hours Other | 2019 July - December 14.75 |
2020 January - June 18.00 |
2020 July - December 13.00 |
Total 45.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Opioid antagonist administration in jails and
medication-assisted treatment availability in prisons and jails.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December 10% |
2020 January - June 20% |
2020 July - December 20% |
Total 17% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication